Hyderabad’s Pharmaceutical Pollution Crisis
This report explores the impacts of pollution from pharmaceutical production sites in the Indian city of Hyderabad, one of the world’s largest “bulk drug” manufacturing hubs, which supplies tonnes of medicines to markets across the European Union and United States every year. The report, commissioned by Nordea, is a follow-up to our February 2016 report and is based on findings from on-the-ground research by investigative agency Ecostorm, interviews with NGO experts and local people, and in-depth analysis of media coverage and academic studies. It presents results from testing of water samples taken at factories and water bodies across Hyderabad in September 2017, which showed high levels of heavy metals and a range of solvents commonly used in pharmaceutical manufacturing. In some cases, these substances were detected at levels orders of magnitude higher than maximum regulatory limits or safe exposure limits, posing a substantial threat to human and ecological health.